πŸ‡ΊπŸ‡Έ FDA
Patent

US 8450379

Methods for treating migraine

granted A61KA61K31/00A61K31/56

Quick answer

US patent 8450379 (Methods for treating migraine) held by Corcept Therapeutics Incorporated expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K31/56, A61K31/573, A61K31/59